Related references
Note: Only part of the references are listed.The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma
Elmas Kasap et al.
TUMOR BIOLOGY (2016)
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Johannes Schoedel et al.
EUROPEAN UROLOGY (2016)
β-Catenin Links von Hippel-Lindau to AuroraKinase A and Loss of Primary Cilia in Renal Cell Carcinoma
Ruhee Dere et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art
J. Michael Randall et al.
CANCER AND METASTASIS REVIEWS (2014)
Genetic and Pharmacological Strategies to Refunctionalize the von Hippel Lindau R167Q Mutant Protein
Zhiyong Ding et al.
CANCER RESEARCH (2014)
Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)
Benedicte Martin et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest
Tiffany A. Coon et al.
CELL CYCLE (2012)
Aurora A overexpression and pVHL reduced expression are correlated with a bad kidney cancer prognosis
Imen Ferchichi et al.
DISEASE MARKERS (2012)
Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes
Martin Sadowski et al.
IUBMB LIFE (2012)
The Size of the Proteasomal Substrate Determines Whether Its Degradation Will Be Mediated by Mono- or Polyubiquitylation
Nitzan Shabek et al.
MOLECULAR CELL (2012)
pVHL Mediates K63-Linked Ubiquitination of nCLU
Jing Xue et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins
Kimberly Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor
Yanlai Lai et al.
PLOS ONE (2011)
The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR
Liang Zhou et al.
PLOS ONE (2011)
Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan
Loreto Carvallo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Taf1 Regulates Pax3 Protein by Monoubiquitination in Skeletal Muscle Progenitors
Stephane C. Boutet et al.
MOLECULAR CELL (2010)
VHL loss causes spindle misorientation and chromosome instability
Claudio R. Thoma et al.
NATURE CELL BIOLOGY (2009)
Oxygen-Regulated β2-Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL
Liang Xie et al.
SCIENCE SIGNALING (2009)
The von hippel-lindau tumor suppressor protein and Egl-9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress
Olga Mikhaylova et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor
Martijn P. Lolkema et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2
Martijn P. Lolkema et al.
FEBS LETTERS (2007)
Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors
Stephane C. Boutet et al.
CELL (2007)
HEF1-Dependent aurora a activation induces disassembly of the primary cilium
Elena N. Pugacheva et al.
CELL (2007)
von Hippel-Lindau: A tumor suppressor links Microtubules to ciliogenesis and cancer development
E. Wolfgang Kuehn et al.
CANCER RESEARCH (2007)
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Claudio R. Thoma et al.
NATURE CELL BIOLOGY (2007)
Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway
Shen Kiat Lim et al.
BIOCHEMICAL JOURNAL (2007)
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein
X Na et al.
EMBO JOURNAL (2003)
von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination
AV Kuznetsova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
A Hergovich et al.
NATURE CELL BIOLOGY (2003)
APC/Fizzy-Related targets Aurora-A kinase for proteolysis
A Castro et al.
EMBO REPORTS (2002)
Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma
K Hamano et al.
JOURNAL OF UROLOGY (2002)
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C
H Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford et al.
HUMAN MOLECULAR GENETICS (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
T Kamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mechanism of regulation of the hypoxia-inducible factor-lα by the von Hippel-Lindau tumor suppressor protein
K Tanimoto et al.
EMBO JOURNAL (2000)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
Recognition of the polyubiquitin proteolytic signal
JS Thrower et al.
EMBO JOURNAL (2000)
Share Paper
